Each tablet contains Zolpidem Tartrate 10 mg.

Zolipid Tablets contain Zolpidem Tartrate, a non-benzodiazepine hypnotic indicated for the short-term treatment of insomnia. It helps reduce sleep latency, promotes the initiation of sleep, and improves overall sleep quality. By selectively acting on specific GABA receptors in the brain, Zolipid provides effective nighttime sedation while minimizing disruption of normal sleep architecture when used as prescribed.

Zolipid Tablets are indicated for the short-term treatment of insomnia, particularly in patients who have difficulty initiating sleep.

Zolpidem Tartrate is a non-benzodiazepine hypnotic that selectively binds to the benzodiazepine-1 (BZ1) receptor subtype of the GABA_A receptor chloride channel complex. By enhancing the inhibitory effects of gamma-aminobutyric acid (GABA), it produces sedative and hypnotic effects that facilitate sleep onset. Modulation of the GABA_A receptor is responsible for its sedative properties while also contributing to anticonvulsant, anxiolytic, and muscle relaxant effects.

The recommended dose is 10 mg orally once daily, taken immediately before bedtime, or as directed by the physician. Patients should ensure they can obtain a full night's sleep after taking the medication.

Zolipid Tablets are contraindicated in patients with known hypersensitivity to Zolpidem Tartrate or any component of the formulation.